Analytical Method Development: Determination of Absorptivity Values – V 2.0
SOP for Determination of Absorptivity Values in UV Spectrophotometry
| Department |
Analytical Method Development |
| SOP No. |
SOP/AMD/092/2025 |
| Supersedes |
SOP/AMD/092/2022 |
| Page No. |
Page 1 of 14 |
| Issue Date |
19/05/2025 |
| Effective Date |
20/05/2025 |
| Review Date |
19/05/2026 |
1. Purpose
This SOP outlines the procedure for determining the absorptivity value (A 1%, 1cm) of Active Pharmaceutical Ingredients (APIs) using UV spectrophotometry, ensuring method standardization, reproducibility, and regulatory compliance with USP and ICH guidelines.
2. Scope
This procedure is applicable to the Analytical Method Development (AMD) department for the determination of absorptivity values of APIs and reference standards used in pharmaceutical formulation and quality control.
3. Responsibilities
- Analytical Chemist: Prepares dilutions, performs UV scans, calculates absorptivity values.
- Reviewer: Validates accuracy of calculations and spectrophotometric readings.
- QA Officer: Ensures adherence to documentation practices and compliance with regulations.
- Head – AMD: Approves determined absorptivity values and ensures SOP compliance.
4. Accountability
The Head of Analytical Method Development is accountable for ensuring that absorptivity values determined using this procedure are scientifically justified, reproducible, and suitable for regulatory submissions and specification building.
5. Procedure
5.1 Principle
- Absorptivity (A 1%, 1cm) is the absorbance of a 1% w/v solution in a 1 cm path length cuvette.
- Calculated using:
A (1%, 1cm) = (A × 100) / C
Where:
- A = absorbance of test solution
- C = concentration in mg/mL
5.2 Selection of Wavelength (λmax)
- Scan test solution from 200–400 nm using UV spectrophotometer.
- Determine wavelength with highest and stable absorbance (λmax).
- Confirm absence of interference from solvent or excipients.
- Document in Annexure-1: Wavelength Scanning Report.
5.3 Standard Solution Preparation
- Accurately weigh 100 mg of API or reference standard.
- Dissolve in solvent (e.g., water, ethanol, methanol) and make up to 100 mL volume to achieve 1 mg/mL (0.1% w/v).
- Further dilute to 0.01% w/v (100 µg/mL) if absorbance exceeds 1.0.
- Use matched quartz cuvettes and record absorbance at λmax.
- Record in Annexure-2: Standard Preparation Log.
5.4 Blank and Instrument Setup
- Use blank solvent (same as used for sample) in reference cell.
- Use spectrophotometer set to 1 nm bandwidth and 1.000 path length (cm).
- Zero instrument with blank before taking absorbance of test solution.
- Confirm baseline stability and document in Annexure-3: Blank Verification Log.
5.5 Calculation of Absorptivity Value
- Use following formula:
A (1%, 1cm) = (Absorbance × 100) / Concentration in mg/mL
- Example: Absorbance = 0.875 at 260 nm; Concentration = 0.01 mg/mL (0.001% w/v)
A (1%, 1cm) = (0.875 × 100) / 0.01 = 8750
- Repeat with at least three concentrations to ensure linearity.
- Record in Annexure-4: Absorptivity Calculation Sheet.
5.6 Verification of Linearity and Precision
- Prepare three dilutions (e.g., 80, 100, 120 µg/mL).
- Measure absorbance and calculate A (1%, 1cm) for each.
- Acceptance Criteria:
- %RSD of A (1%, 1cm) ≤ 2.0%
- Linearity: R² ≥ 0.995
- Document in Annexure-5: Linearity and Precision Report.
5.7 Application in Assay and Dissolution
- Use A (1%, 1cm) value to convert absorbance to concentration for:
- Single-point assay
- Routine dissolution testing
- Analytical method equivalency checks
- Ensure that same solvent, cuvette, and path length are used in all subsequent applications.
6. Abbreviations
- UV: Ultraviolet
- API: Active Pharmaceutical Ingredient
- λmax: Wavelength of Maximum Absorbance
- A (1%, 1cm): Absorptivity of 1% solution in 1 cm cell
- RSD: Relative Standard Deviation
7. Documents
- Wavelength Scanning Report – Annexure-1
- Standard Preparation Log – Annexure-2
- Blank Verification Log – Annexure-3
- Absorptivity Calculation Sheet – Annexure-4
- Linearity and Precision Report – Annexure-5
8. References
- USP <857> – Ultraviolet-Visible Spectroscopy
- ICH Q2(R1) – Validation of Analytical Procedures
- Ph. Eur. and IP Monographs on UV Absorptivity
- FDA Guidance on Analytical Methods
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
|
|
|
| Department |
|
|
|
11. Annexures
Annexure-1: Wavelength Scanning Report
| Sample ID |
Solvent |
Scan Range |
λmax (nm) |
| API-UV-212 |
Methanol |
200–400 nm |
262 |
Annexure-2: Standard Preparation Log
| Substance |
Weight (mg) |
Solvent |
Volume (mL) |
Prepared By |
| API-212 |
100.0 |
Methanol |
100 |
Sunita Reddy |
Annexure-3: Blank Verification Log
| Blank Solvent |
Absorbance at λmax |
Conclusion |
| Methanol |
0.001 |
No Interference |
Annexure-4: Absorptivity Calculation Sheet
| Sample |
Concentration (mg/mL) |
Absorbance |
A (1%, 1cm) |
| API-212 |
0.01 |
0.853 |
8530 |
Annexure-5: Linearity and Precision Report
| Concentration (µg/mL) |
Absorbance |
A (1%, 1cm) |
| 80 |
0.682 |
8525 |
| 100 |
0.853 |
8530 |
| 120 |
1.021 |
8517 |
Revision History:
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 04/05/2025 |
2.0 |
Annexures expanded to include linearity and blank interference |
Annual SOP Update |
|